Prof. Paolo Zamboni, 10th International Symposium on Endovascular Therapeutics (SITE 2013) – The current rationale for CCSVI treatment early clinical results from a pilot study FULL PDF: https://docs.google.com/file/d/0Bxspl6NsbdETTWhQYlVlSjI1WDA

“...Conclusions: PTA of MS patients with CCSVI increased CSF flow and decreased CSF velocity, which are indicative of improved venous parenchyma drainage....”